HCPLive Network
Latest Specialty Pharmacy Headlines
Thursday, October 30, 2014
By Davy James, Associate Editor
Bortezomib found to effectively treat chronic graft-versus-host disease.
Thursday, October 30, 2014
By Davy James, Associate Editor
Production capacity to be expanded for millions of doses to be available during 2015.
Thursday, October 30, 2014
Paul Jardina brings more than 20 years of health care industry experience to Onco360.
Wednesday, October 29, 2014
By Davy James, Associate Editor
Methotrexate injection treats patients with rheumatoid arthritis, polyarticular-course juvenile idiopathic arthritis, and psoriasis.
Wednesday, October 29, 2014
By Davy James, Associate Editor
New recommendations for the removal of protective gear highlight the need for enhanced technologies.
Tuesday, October 28, 2014
By Davy James, Associate Editor
Sovriad found to have caused significant increase in blood bilirubin levels in deceased patients.
Tuesday, October 28, 2014
By Davy James, Associate Editor
More than 1000 cases of enterovirus D68 have now been reported across 47 states.
Tuesday, October 28, 2014
By Eileen Oldfield, Associate Editor
A dendritic cell vaccine for MS attacks the condition early, while preserving the immune system.
Monday, October 27, 2014
By Davy James, Associate Editor
Accelerated approval for pembrolizumab based on tumor response rate and durability of response.
Monday, October 27, 2014
By Davy James, Associate Editor
Federal officials question state policies that mandate a 21-day quarantine of health care workers who treat Ebola patients.
Physician's Money Digest
The term “venture capitalist” has been bannered across all media for years now, but most folks outside that cloistered sub-culture here in Silicon Valley know little about it.
There have been quite a few hot IPOs this year. Alibaba and GoPro to name just a couple. But the real money was made before these companies even went public.